BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 10583224)

  • 41. High prevalence of occult hepatitis B virus infection in patients with B cell non-Hodgkin's lymphoma.
    Chen MH; Hsiao LT; Chiou TJ; Liu JH; Gau JP; Teng HW; Wang WS; Chao TC; Yen CC; Chen PM
    Ann Hematol; 2008 Jun; 87(6):475-80. PubMed ID: 18327583
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hepatitis C virus infection in patients with non-Hodgkin's lymphoma.
    Ferri C; Caracciolo F; Zignego AL; La Civita L; Monti M; Longombardo G; Lombardini F; Greco F; Capochiani E; Mazzoni A
    Br J Haematol; 1994 Oct; 88(2):392-4. PubMed ID: 7803287
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevalence of hepatitis B, hepatitis C, and GB virus C/hepatitis G virus infections in liver disease patients and inhabitants in Ho Chi Minh, Vietnam.
    Kakumu S; Sato K; Morishita T; Trinh KA; Nguyen HB; Banh VD; Do HC; Nguyen HP; Nguyen VT; Le TT; Yamamoto N; Nakao H; Isomura S
    J Med Virol; 1998 Apr; 54(4):243-8. PubMed ID: 9557289
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Overt and occult hepatitis B virus infection in adult Sudanese HIV patients.
    Mudawi H; Hussein W; Mukhtar M; Yousif M; Nemeri O; Glebe D; Kramvis A
    Int J Infect Dis; 2014 Dec; 29():65-70. PubMed ID: 25449238
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Performance of rapid diagnostic tests for detection of Hepatitis B and C markers in HIV infected patients.
    Barbosa JR; Colares JKB; Flores GL; Cortes VF; Miguel JC; Portilho MM; Marques VA; Potsch DV; Brandão-Mello CE; Amendola-Pires M; Pilotto JH; Lima DM; Lampe E; Villar LM
    J Virol Methods; 2017 Oct; 248():244-249. PubMed ID: 28782578
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Detection of viral antigens in renal tissue of glomerulonephritis patients without serological evidence of hepatitis B virus and hepatitis C virus infection.
    Kong D; Wu D; Wang T; Li T; Xu S; Chen F; Jin X; Lou G
    Int J Infect Dis; 2013 Jul; 17(7):e535-8. PubMed ID: 23474175
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Extrahepatic disorders of HCV infection: a distinct entity of B-cell neoplasia?
    Libra M; Polesel J; Russo AE; De Re V; Cinà D; Serraino D; Nicoletti F; Spandidos DA; Stivala F; Talamini R
    Int J Oncol; 2010 Jun; 36(6):1331-40. PubMed ID: 20428756
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevalence of Hepatitis B and C virus infection among alcoholic individuals: importance of screening and vaccination.
    Cortes VF; Taveira A; Cruz HM; Reis AA; Cezar JS; Silva BS; D'Assunção CF; Lampe E; Villar LM
    Rev Inst Med Trop Sao Paulo; 2017; 59():e47. PubMed ID: 28793018
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hepatitis C virus infection and chronic liver disease in Ethiopia where hepatitis B infection is hyperendemic.
    Tsega E; Nordenfelt E; Hansson BG
    Trans R Soc Trop Med Hyg; 1995; 89(2):171-4. PubMed ID: 7539952
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Analysis of hepatitis B virus infection in 1424 patients with different pathological types of lymphoma (2018-2022): A real-world, retrospective study.
    Li Z; Guo W; Zhao Y; Wang H; Guo J; Li Z; Wang B; Cao L; Xu J; Young KH; Bai O
    Cancer Med; 2024 May; 13(10):e7284. PubMed ID: 38752442
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Outcome of hepatitis B and C virus infection on graft function after renal transplantation.
    Behzad-Behbahani A; Mojiri A; Tabei SZ; Farhadi-Andarabi A; Pouransari R; Yaghobi R; Rahsaz M; Banihashemi M; Malek-Hosseini SA; Javid A; Bahador A; Reisjalali A; Behzadi S; Salehipour M; Salahl A; Davari R; Janghorban P; Torb A; Salah AR
    Transplant Proc; 2005 Sep; 37(7):3045-7. PubMed ID: 16213299
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Hepatita B and C virus infections in patients with hepatocellular carcinoma].
    Crespo J; Dueñas C; Sánchez-Antolín G; Fábrega E; Carte B; Pons-Romero F
    Med Clin (Barc); 1996 Feb; 106(7):241-5. PubMed ID: 8667672
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hepatitis C-related hepatocellular carcinoma. Prevalence and significance.
    Resnick RH; Koff R
    Arch Intern Med; 1993 Jul; 153(14):1672-7. PubMed ID: 7687423
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia.
    Tsatsralt-Od B; Takahashi M; Nishizawa T; Endo K; Inoue J; Okamoto H
    J Med Virol; 2005 Dec; 77(4):491-9. PubMed ID: 16254981
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Does hepatitis C virus infection contribute to hepatocellular carcinoma in Hong Kong?
    Leung NW; Tam JS; Lai JY; Leung TW; Lau WY; Shiu W; Li AK
    Cancer; 1992 Jul; 70(1):40-4. PubMed ID: 1318777
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.
    Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H
    Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anti-HCV and HCV-RNA prevalence and clinical correlations in cases with non-Hodgkin's lymphoma.
    Paydas S; Kilic B; Yavuz S; Disel U; Tanriverdi K; Sahin B; Burgut R
    Am J Hematol; 2003 Oct; 74(2):89-93. PubMed ID: 14508793
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hepatitis C virus, mixed cryoglobulinaemia and non-Hodgkin's lymphoma.
    Mazzaro C; Efremov DG; Burrone O; Pozzato G
    Ital J Gastroenterol Hepatol; 1998 Aug; 30(4):428-34. PubMed ID: 9789144
    [TBL] [Abstract][Full Text] [Related]  

  • 59. B-cell non-Hodgkin's lymphoma and hepatitis C virus infection: a systematic review.
    Negri E; Little D; Boiocchi M; La Vecchia C; Franceschi S
    Int J Cancer; 2004 Aug; 111(1):1-8. PubMed ID: 15185336
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevalence of elevated ALT values, HBsAg, and anti-HCV in the primary care setting and evaluation of guideline defined hepatitis risk scenarios.
    Wolffram I; Petroff D; Bätz O; Jedrysiak K; Kramer J; Tenckhoff H; Berg T; Wiegand J;
    J Hepatol; 2015 Jun; 62(6):1256-64. PubMed ID: 25617500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.